These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 22206889)
1. Isolation and characterisation of degradant impurities in dipyridamole formulation. Venkata Subbaiah B; Sree Ganesh KK; Vamsi Krishna G; Vyas K; Vasu Dev R; Subramanyam Reddy K J Pharm Biomed Anal; 2012 Mar; 61():256-64. PubMed ID: 22206889 [TBL] [Abstract][Full Text] [Related]
2. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis. Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243 [TBL] [Abstract][Full Text] [Related]
3. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS. Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334 [TBL] [Abstract][Full Text] [Related]
4. Identification of gentamicin impurities by liquid chromatography tandem mass spectrometry. Grahek R; Zupancic-Kralj L J Pharm Biomed Anal; 2009 Dec; 50(5):1037-43. PubMed ID: 19577403 [TBL] [Abstract][Full Text] [Related]
5. Isolation, identification and characterization of degradant impurities in Tolterodine tartrate formulation. Prakash L; Himaja M; Subbaiah BV; Vasudev R; Srinivasulu C; Haribabu R J Pharm Biomed Anal; 2014 Mar; 90():215-21. PubMed ID: 24384498 [TBL] [Abstract][Full Text] [Related]
6. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation. Thomas S; Mathela CS; Agarwal A; Paul SK J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571 [TBL] [Abstract][Full Text] [Related]
7. Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide. Kancherla P; Keesari S; Alegete P; Khagga M; Das P Drug Test Anal; 2018 Jan; 10(1):212-221. PubMed ID: 28421713 [TBL] [Abstract][Full Text] [Related]
8. Isolation, structural elucidation and characterization of impurities in Cefdinir. Rao KV; Rani A; Reddy AV; Bharathi CH; Dandala R; Naidu A J Pharm Biomed Anal; 2007 Mar; 43(4):1476-82. PubMed ID: 17174507 [TBL] [Abstract][Full Text] [Related]
9. Identification, isolation and characterization of potential degradation product in risperidone tablets. Bharathi Ch; Chary DK; Kumar MS; Shankar R; Handa VK; Dandala R; Naidu A J Pharm Biomed Anal; 2008 Jan; 46(1):165-9. PubMed ID: 17981421 [TBL] [Abstract][Full Text] [Related]
10. Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MS(n). Thomas S; Paul SK; Shandilya S; Agarwal A; Saxena N; Awasthi AK; Matta Hb; Vir D; Mathela CS Analyst; 2012 Aug; 137(15):3571-82. PubMed ID: 22733388 [TBL] [Abstract][Full Text] [Related]
11. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate. Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296 [TBL] [Abstract][Full Text] [Related]
12. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride. Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955 [TBL] [Abstract][Full Text] [Related]
13. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry. Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients. Zech SG; Carr M; Mohemmad QK; Narasimhan NI; Murray C; Rozamus LW; Dalgarno DC J Antibiot (Tokyo); 2011 Sep; 64(9):649-54. PubMed ID: 21792211 [TBL] [Abstract][Full Text] [Related]
15. Structural identification and characterization of impurities in ceftizoxime sodium. Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586 [TBL] [Abstract][Full Text] [Related]
16. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate. Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198 [TBL] [Abstract][Full Text] [Related]
17. Identification, synthesis and quantification of process-related impurities in auraptene. Li YG; Chen HF; Tu MZ; Zhang PZ; Wang XY; Yuan JB; Yang WL J Pharm Biomed Anal; 2011 Sep; 56(2):191-9. PubMed ID: 21705169 [TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of degradation impurities in epirubicin hydrochloride injection. Kumar D; Tomar RS; Deolia SK; Srivastava R; Mitra M; Tyagi S J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):45-53. PubMed ID: 18539101 [TBL] [Abstract][Full Text] [Related]